PERCEPT - myeloma transplant prehab study

Not Applicable

Completed

• Conditions: Myeloma; Cancer

• Registration Number: ISRCTN15875290
• Lead Sponsor: niversity College London

Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32001493 protocol (added 03/02/2020) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35396313/ Protocol adaptations following COVID-19 pandemic (added 11/04/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36794394/ (added 22/02/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37069548/ results from embedded qualitative semi-structured interview study (added 26/04/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-02-13
• Study Completion: 2021-09-27
• Last Update Posted: 8 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Adult patients referred to the UCLH transplant multidisciplinary team (MDT) and awaiting autologous stem cell transplant as treatment for myeloma
2. Clinically able to carry out an exercise training programme on a regular basis
3. Patients must have a good command of written and spoken English
4. Willing and able to provide written informed consent

Exclusion Criteria

1. Patients with known spinal instability, spinal cord compression or neurological deficits
2. Those who have had recent (within six weeks) spinal surgery or other surgery for pathological fractures
3. Abnormal resting ECG and/or unstable angina
4. Those deemed unsuitable to partake by the MDT
5. Unable or unwilling to undertake an exercise programme on a regular basis

Study & Design

• Study Type: Interventional
• Study Design: Not specified